Compare IRIS Regtech Sol with Similar Stocks
Stock DNA
Software Products
INR 556 Cr (Micro Cap)
18.00
24
0.00%
-0.52
14.00%
2.57
Total Returns (Price + Dividend) 
IRIS Regtech Sol for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

IRIS Regtech Solutions Ltd Valuation Shifts Signal Heightened Price Risk
IRIS Regtech Solutions Ltd has experienced a notable shift in its valuation parameters, moving from an already expensive status to being classified as very expensive. This change, reflected in key metrics such as the price-to-earnings (P/E) ratio and price-to-book value (P/BV), raises questions about the stock’s price attractiveness relative to its historical averages and peer group within the software products sector.
Read full news articleAre IRIS Regtech Solutions Ltd latest results good or bad?
IRIS Regtech Solutions Ltd's latest financial results for Q4 FY26 present a mixed operational picture. The company reported consolidated net sales of ₹39.15 crores, reflecting a year-on-year growth of 31.64%, which indicates strong demand for its regulatory technology solutions. This growth is further supported by a sequential increase of 10.00% from the previous quarter. However, the consolidated net profit for the same period was ₹4.15 crores, showing a significant year-on-year growth of 47.16%, but a sequential decline of 21.85% from the prior quarter, raising concerns about earnings consistency. The operating margin, excluding other income, was reported at 13.69%, which represents a contraction from 18.49% in the same quarter of the previous year. This margin compression is attributed to rising employee costs, which increased significantly and now account for a substantial portion of net sales. The ret...
Read full news article
IRIS Regtech Q4 FY26: Strong Profit Growth Masks Valuation Concerns
IRIS Regtech Solutions Ltd., a micro-cap software products company specialising in regulatory technology solutions, reported consolidated net profit of ₹4.15 crores for Q4 FY26, marking a 47.16% year-on-year increase from ₹2.82 crores in Q4 FY25. However, the quarter-on-quarter performance revealed a concerning 21.85% decline from ₹5.31 crores in Q3 FY26, raising questions about earnings sustainability. The company's shares, trading at ₹237.00 as of May 15, 2026, have declined 0.63% post-results, reflecting investor caution despite the annual growth trajectory.
Read full news article Announcements 
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 4 FIIs (1.87%)
Deepta Rangarajan (28.77%)
Subhkam Ventures I Private Limited (7.77%)
35.83%
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
YoY Growth in quarter ended Mar 2026 is 31.64% vs -2.01% in Mar 2025
YoY Growth in quarter ended Mar 2026 is 47.16% vs -40.13% in Mar 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 5.25% vs 14.53% in Sep 2024
Growth in half year ended Sep 2025 is 1,654.57% vs 196.44% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 6.48% vs 16.64% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 1,098.24% vs 156.53% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 17.16% vs 7.21% in Mar 2025
YoY Growth in year ended Mar 2026 is 870.76% vs 49.94% in Mar 2025






